INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Multiple NC students upset by yearbook entries
Multiple students at North Central High School are upset about what they consider disrespectful content in their 2015 yearbook.
TK takes Dave Furst for a lap on live TV
Tony Kanaan took Dave Furst for a lap around the IMS on live TV.
Suspect arrested in fatal hit-and-run
A pedestrian was killed in a hit-and-run crash early Wednesday on the city's south side near an overpass of Interstate 65.
Joe Hogsett proposes major city ethics changes
Indianapolis mayoral candidate Joe Hogsett, D, announced a plan Wednesday to improve the city’s ethics code and provide more transparency.
Program aims to help inmates beyond prison walls
A local program aims to stop meth-addicted criminals from returning to prison.